Metraipolis › archive › dc_b2bcd7195774
A comparative review of economic evaluations for immune checkpoint inhibitors in early stage and advanced stage cancer: focusing on pembrolizumab — Europe PMC PMID:41948717
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41948717
- DOI
- 10.3389/fphar.2026.1717776
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T01:50:40.862Z
- SHA-256 of the archived text
a6cd6cf91b6bd5f11cb238e633496372ee2fe151d30b3cf99416bb32485e7902- Stable URL of this page
https://metraipolis.com/documento/dc_b2bcd7195774
How to cite
A comparative review of economic evaluations for immune checkpoint inhibitors in early stage and advanced stage cancer: focusing on pembrolizumab — Europe PMC PMID:41948717 — Europe PMC (en), https://europepmc.org/article/MED/41948717 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2bcd7195774 (Metraipolis archive dc_b2bcd7195774, sha256 a6cd6cf91b6bd5f11cb238e633496372ee2fe151d30b3cf99416bb32485e7902)
BibTeX
@misc{dcb2bcd7195774,
title = {A comparative review of economic evaluations for immune checkpoint inhibitors in early stage and advanced stage cancer: focusing on pembrolizumab — Europe PMC PMID:41948717},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41948717},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2bcd7195774; sha256 a6cd6cf91b6bd5f11cb238e633496372ee2fe151d30b3cf99416bb32485e7902},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41948717. Agents can read the archived copy with the MCP tool read_document.